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Abstract Ballistic transfection, based on cell and tissue 
bombardment by the tungsten and gold microparticles covered 
with the gene DNA, was used for the delivery of a bacterial [3- 
galactosidase and a full-length cDNA copy of the human 
dystrophin genes into mouse skeletal muscles. CMV-lacZ, 
SV40-1acZ, LTR-lacZneo and full-length cDNA dystrophin 
(pDMD-1, approximately 16 kb) in eukaryotic expression vector 
pJ OMEGA driven by mouse leukaemia virus promotor 
(pMLVDy) were used throughout he studies. Musculus glutaeus 
superficialis of C57BL/6J and quadriceps femoris of mdx male 
mice were opened surgically under anesthesia nd bombarded by 
means of the gene-gun technique originally developed by us. 
Different mixtures of gold and tungsten particles at ratios of 4:1, 
1:1, 1:4 were applied. X-gal assay revealed marked [5-gal 
activity, both in total muscles and whole muscle fibers on 
histological sections, up to three months after transfection. The 
most intensive staining was observed after SV40-1acZ delivery. 
No staining was detected with LTR-lacZneo DNA as well as in 
untreated muscles. The higher tungsten particle concentration in 
the bombardment mixture correlated with more intense X-gal 
staining. At the gold/tungsten ratio of 1:4 the microparticles 
penetrated the musculus glutaeus superficialis and transfected the 
underlying musculus glutaeus medius as well. Immuno-cytochem- 
ical assay for human dystrophin revealed dystrophin positive 
myofibers (DPM) in the bombarded area up to two months after 
transfection. The proportion of DMP varied from 2.5% on day 
17 up two 5% on day 60 after bombardment compared to nly 
0.5% in the control mdx mice. These results suggest the 
applicability of particle bombardment for gene delivery into 
muscle fibers. 
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monogenic diseases such as Duchenne muscular dystrophy 
(DMD) [14]. Several attempts to introduce foreign genes 
into muscle tissues have been undertaken during the last dec- 
ade. After injection of bacterial [3-galactosidase and some oth- 
er reporter genes into mouse muscle tissue their expression 
was demonstrated up to two months [5]. 
It has been repeatedly shown that human dystrophin gene 
when introduced into skeletal muscle of mdx mice (biologi- 
cal model of DMD) retains the ability for efficient expression 
[610]. 
In the most of these studies direct DNA injection via stand- 
ard syringe needles was applied. We decided to use the ballis- 
tic (gene-gun) approach based on the target object bombard- 
ment by heavy metal (tungsten or gold) microparticles coated 
with DNA [11-13]. The approach has proved itself to be 
highly efficient for animal cell and tissues transfection in situ 
[13-19], including muscle transfection [18,19]. One to three 
days after bombardment he activities of the introduced 
CAT [18] and luciferase [19] genes were detected in mouse 
muscles. However, the methods of detection used in these 
investigations ( tudy of organ extracts) did not allow elucida- 
tion whether gene expression was confined to the muscle fibers 
themselves or could be attributed to some other cell types 
such as connective tissue. 
The main goal of the present study was to estimate the 
capacity of ballistic method to deliver reporter genes as well 
as therapeutic dystrophin gene into muscle fibers in vivo. To 
our knowledge, the present study describes the first attempt o 
exploit microparticle bombardment technique for the intro- 
duction of dystrophin gene into skeletal muscle fibers of 
mdx mice. 
2. Materials and methods 
1. Introduction 
Introduction of exogenous gene constructions into skeletal 
muscle tissues is regarded as a possible approach towards gene 
therapy of a number of inherited disorders including common 
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2.1. Manipulation with animals 
C57BL/6J and mdx dystrophin deficient male mice, two-eight 
weeks old, were used throughout the studies. Musculi glutaeus uper- 
ficialis and quadriceps femoris were opened surgically under avertin 
anesthesia and bombarded through the fascia by means of gene-gun 
technique as indicated below. After the bombardment, the skin was 
stitched up and the mice were returned to the animal house. 100% of 
animals survived the procedure. The animals were killed from 24 h to 
three months later, the bombarded area of the muscle was taken for 
X-gal or dystrophin assays [10]. 
In parallel experiments, both water solutions and calcium phos- 
phate precipitates of plasmid DNA were injected into muscles in the 
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Fig. 1. X-gal positive blue stained area in gene-bombarded C57BL/ 
6J mouse musculus glutaeus uperficialis three months after transfec- 
tion with SV40-1acZ DNA. Total muscle preparation. Approximate 
size of the stained area is 1.5 x 1 ram. 
same amount as in the gene-gun experiments. Untreated muscles and 
those after injection of 13-galactosidase protein water solution were 
used as controls. 
2.2. Transfection 
The shooting technology was mainly similar to that described pre- 
viously [15,16]. The distance between the end of the barrel and the 
tissue surface was about 10 cm. To reduce the contamination of tis- 
sues with toxic products of the explosive charge, two diaphragms with 
the center apertures of increasing diameter have been placed between 
the barrel and the bombarded tissue. The first diaphragm contains a 
metal grid 1.5 mmx 1.5 mm mesh in size and the second one has a 
grid 0.14 mmx0.14 mm mesh in size. The first grid is placed near the 
end of the barrel to decrease cell damage by dispersing particles of a
destroyed macroprojectile. The second grid located as close as possi- 
ble to the bombarded tissues disintegrates any conglomerates of metal 
microparticles formed in the course of DNA precipitation. Both grids 
substantially facilitate the efficiency of the transfection. 
The golden (1 /am in diameter) and tungsten (1~, grn in diameter) 
microparticles alone, or in a mixture in different ratios (4:1, 1:1, 1:4 
respectively) were used. 20-30/ag of circular plasmid DNA was taken 
per shot. 
A 
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CMV-IacZ, SV40-1acZ, LTR-lacZneo and full-length cDNA dystro- 
phin (pDMD-1, approximately 16 kb) in eukaryotic expression vector 
p14 driven by mouse leukemia virus promotor MLV, pMLVDy [10] 
were used throughout the studies. 
Plasmid DNA was prepared by the standard lysozyme/alkaline lysis 
followed by CsCI gradient centrifugation. Calcium phosphate precip- 
itation [12] was used to coat the particles with plasmid DNA. 20~30/al 
of a DNA solution (1 mg]ml) added to 10-15 mg of microparticles 
were taken per one shot. 
2.3. Determination of transgene activities 
The presence of bacterial [3-galactosidase in muscle fibers and tis- 
sues was detected using standard X-gal assay both in blocks of total 
muscle or on cryosections. 
For dystrophin immunostaining, muscle cryosections were treated 
with a protein G purified rabbit polyclonal ntibody (P6) raised 
against the C-terminus of dystrophin and subsequently with FITZ 
or horseradish peroxidase l b lled sheep anti-rabbit IgG (secondary 
antibody). 
3. Results and discussion 
Three days after transfection, 13-gal assay of gene-bom- 
barded muscle revealed typical blue stained areas (up to 
3 X 4 mm). The expression was detected up to three months 
after transfection (Fig. 1, the later periods were not studied). 
The staining was most conspicuous after application of SV40- 
lacZ construction delivery. No specific staining was detected 
in experiments with LTR-lacZneo DNA and in untreated 
muscles. 
After direct intramuscular injection of pCMV-LacZ DNA, 
marked but rather weak X-gal staining was observed. Direct 
injections of bacterial [3-galactosidase protein resulted in the 
appearance of blue stained areas. 
In all these experiments, only superficial muscles contained 
the stained areas, most likely due to the limited particle pen- 
etration into the muscle tissue. The investigation carried out 
on serial cryosections across the bombarded muscles con- 
firmed this assumption. After the bombardment with gold 
B 
Fig. 2. X-gal positive muscle fibers in musculus glutaeus medius of C57BL/6J mouse three days after ballistic introduction of SV40-1acZ DNA. 
A: Longitudinal section; B: cross-section. 
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Fig. 3. Clusters of dystrophin positive muscle fibers in mu lulus quadriceps femoris of mdx mice twelve days after ballistic introduction of a full- 
length eDNA copy of the human dystrophin ge es (pDMDdy). A: FITC-labelled secondary antibodies. A.a: Bombarded uscl  (experiment). 
A.b: Non-bombarded muscle (negative control). B: Horseradish peroxidase secondary antibodies. 
particles 1.04.0 mm in size the deepness of the particle pen- 
etration did not exceed 0.5 mm. 
To improve the bombardment conditions we used the mix- 
ture of gold and tungsten microparticles. Experiments showed 
that the higher was tungsten particle concentration, the thick- 
er was the X-gal stained muscle layer. At the gold/tung- 
sten ratio of 1:4, the microparticles penetrated through the 
musculus glutaeus superfieialis and transfected the underly- 
ing musculus glutaeus medius as well. Thus, under these con- 
ditions the deepness of gene-gun transfections wa at least 
4 mm. 
Further experiments were carried out using these newly 
developed bombardment conditions. 
In the next series of experiments, [3-gal expression was 
studied in cross-sections of the ballistically transfected muscle 
fibers of musculi glutaeus uperficialis and glutaeus medius. The 
X-gal assay revealed intense and massive blue staining in 
whole muscle fibers (Fig. 2). The experiments thus proved 
that the foreign gene introduced ballistically into mouse 
muscle is expressed in its fibers. 
The technique optimized using the bacterial 13-galactosidase 
gene was then applied in the studies with the human dystro- 
phin gene construction. 
Full cDNA copy of a human dystrophin gene, pMSVDy, 
was introduced into musculus quadriceps femoris of mdx mice 
which were then killed 3 60 days after bombardment. A num- 
ber of mdx mouse muscle fibers in bombarded area were 
found to be dystrophin positive. The proportion of dystrophin 
positive myofibers (DPM) varied from 2.5% on day 17 up to 
5% on day 60 after bombardment, compared to only 0.5'V~ in
322 A. I~ Zelenin et al.IFEBS Letters 414 (1997) 319-322 
the control mdx mice of the same age. Clusters comprising 
25 30 DMP fibers running at least through 350-400 microns 
of successive histological sections were of special interest (Fig. 
3). 
The results obtained clearly demonstrate he applicability of 
gene-gun technique for efficient transfection of muscle fibers 
by foreign genes. 
Complementary DNA copies of the human dystrophin gene 
were introduced by particle bombardment into the skeletal 
muscles of mdx mice and were shown to be expressed in 
clusters of fibers for at least two months. The area of gene 
expression after ballistic transfection was significantly in- 
creased compared to that after direct injection of naked plas- 
mid into the muscle of mdx mice. 
The actual proportion of DPM is still too small to be con- 
sidered seriously for gene therapy studies. Nonetheless, in 
combination with some other new sophisticated vectors (ad- 
enoviruses, cationic liposomes, complex vectors, etc.) the bal- 
listic transfection might be used not only in gene therapy of 
muscle genetic diseases but also for heterologous transgene 
delivery and prolonged expression in this tissue. Further 
investigations of transfection efficiency of the gene-gun 
technique combined with other vector systems are now in 
progress. 
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